URL details: www.exkivity-update.com/patient

URL title: EXKVITY HCP
URL paragraphs: Following discussions with the U.S. Food and Drug Administration (FDA), Takeda announced the initiation of the withdrawal of EXKIVITY (mobocertinib) on October 2, 2023. As of April 8, 2024, Takeda will no longer provide EXKIVITY commercially in the U.S. ma
URL last crawled: 2024-07-26
URL speed: 514.000 MB/s, downloaded in 0.001 seconds